111 Capital Raises Stock Holdings in Intuitive Surgical, Inc. $ISRG

111 Capital increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 59.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 5,658 shares of the medical equipment provider’s stock after buying an additional 2,116 shares during the period. Intuitive Surgical comprises approximately 0.7% of 111 Capital’s investment portfolio, making the stock its 24th biggest holding. 111 Capital’s holdings in Intuitive Surgical were worth $3,204,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also modified their holdings of the stock. Draper Asset Management LLC increased its stake in Intuitive Surgical by 41.9% in the 4th quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock valued at $2,848,000 after purchasing an additional 1,485 shares in the last quarter. Procyon Advisors LLC increased its stake in Intuitive Surgical by 787.8% in the 4th quarter. Procyon Advisors LLC now owns 4,794 shares of the medical equipment provider’s stock valued at $2,715,000 after purchasing an additional 4,254 shares in the last quarter. Oppenheimer Asset Management Inc. increased its stake in Intuitive Surgical by 29.3% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock valued at $40,255,000 after purchasing an additional 16,119 shares in the last quarter. Vanguard Group Inc. increased its stake in Intuitive Surgical by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after purchasing an additional 263,828 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its stake in Intuitive Surgical by 22.5% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 11,463 shares of the medical equipment provider’s stock valued at $5,127,000 after purchasing an additional 2,102 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total value of $236,730.00. Following the sale, the director owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,448 shares of company stock worth $3,224,404 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on ISRG shares. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Mizuho set a $525.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a research note on Monday, April 13th. TD Cowen dropped their price objective on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Raymond James Financial dropped their price objective on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. Finally, Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $573.63.

Intuitive Surgical Trading Up 0.8%

Shares of ISRG stock opened at $422.06 on Friday. The firm has a 50-day moving average price of $447.24 and a 200 day moving average price of $501.02. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88. The company has a market capitalization of $149.48 billion, a price-to-earnings ratio of 51.16, a PEG ratio of 3.34 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the previous year, the company posted $1.81 EPS. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.